ZA862812B - Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods - Google Patents

Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods

Info

Publication number
ZA862812B
ZA862812B ZA862812A ZA862812A ZA862812B ZA 862812 B ZA862812 B ZA 862812B ZA 862812 A ZA862812 A ZA 862812A ZA 862812 A ZA862812 A ZA 862812A ZA 862812 B ZA862812 B ZA 862812B
Authority
ZA
South Africa
Prior art keywords
methods
antigens
aids
virus
obtaining
Prior art date
Application number
ZA862812A
Other languages
English (en)
Inventor
Luc Montagnier
Francoise Rey
Bernard Krust
Francois Clavel
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient filed Critical Pasteur Institut
Publication of ZA862812B publication Critical patent/ZA862812B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA862812A 1985-04-15 1986-04-15 Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods ZA862812B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR858505676A FR2580177B2 (fr) 1985-04-15 1985-04-15 Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees

Publications (1)

Publication Number Publication Date
ZA862812B true ZA862812B (en) 1986-12-30

Family

ID=9318255

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA862812A ZA862812B (en) 1985-04-15 1986-04-15 Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods

Country Status (14)

Country Link
US (1) US5550052A (xx)
EP (1) EP0206842A1 (xx)
JP (1) JPS61286756A (xx)
KR (1) KR860008275A (xx)
AR (1) AR241315A1 (xx)
AU (1) AU5612686A (xx)
CA (1) CA1280072C (xx)
DK (1) DK169986A (xx)
FR (1) FR2580177B2 (xx)
GR (1) GR860987B (xx)
NZ (1) NZ215841A (xx)
OA (1) OA08278A (xx)
PT (1) PT82396B (xx)
ZA (1) ZA862812B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
JPS62182662A (ja) * 1986-02-06 1987-08-11 Fujirebio Inc ウイルス抗体検出用試薬
DK155886D0 (da) * 1986-04-04 1986-04-04 Bo Arne Hofmann Vaccine og fremgangsmaade til fremstilling af denne
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
AU609447B2 (en) * 1987-02-19 1991-05-02 Nissin Shokuhin Kabushiki Kaisha Methods and materials for hiv detection and therapy
US5217895A (en) * 1987-02-19 1993-06-08 Nissin Shokuhin Kabushiki Kaisha Monoclonal anti-idiotypic antibodies specific for anti-T4 antibodies and cross-reactive with HIV
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen
IL95738A (en) * 1989-09-23 1996-11-14 Hoechst Ag Antibodies against the well-preserved amino acid sequences of insulin, a process for their preparation and use in immunoassay
FR2782168B1 (fr) * 1998-08-10 2000-11-03 Ass Pour Le Dev De La Biothera Nouvelles applications des sarcolectines et de leurs derives en diagnostic et therapeutique
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
LT2691530T (lt) 2011-06-10 2018-08-10 Oregon Health & Science University Cmv glikoproteinai ir rekombinantiniai vektoriai
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675295A (en) * 1981-10-28 1987-06-23 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing subculturable lymphokine-producing human T cell hybridomas
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
AU583473B2 (en) * 1983-04-27 1989-05-04 President And Fellows Of Harvard College Method and products for detection of human t cell leukemia virus
EP0136798A3 (en) * 1983-08-25 1986-02-19 Biotech Research Laboratories Inc. Titre plate and assay kit for detection of antibodies in human serum and their production and use
US4665032A (en) * 1984-06-28 1987-05-12 Cornell Research Foundation, Inc. Human T cell hybridomas which produce immunosuppressive factors
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease

Also Published As

Publication number Publication date
US5550052A (en) 1996-08-27
KR860008275A (ko) 1986-11-14
GR860987B (en) 1986-08-11
AU5612686A (en) 1986-10-23
JPS61286756A (ja) 1986-12-17
DK169986D0 (da) 1986-04-15
PT82396A (fr) 1986-05-01
FR2580177B2 (fr) 1989-06-02
DK169986A (da) 1986-10-16
NZ215841A (en) 1991-04-26
AR241315A1 (es) 1992-05-29
OA08278A (fr) 1987-10-30
PT82396B (pt) 1988-08-17
EP0206842A1 (fr) 1986-12-30
FR2580177A2 (fr) 1986-10-17
CA1280072C (fr) 1991-02-12

Similar Documents

Publication Publication Date Title
ZA862812B (en) Antigens related to envelope glycoprotein of the virus of aids,methods of obtaining these antigens and means employed in these methods
NZ211880A (en) Immunogenic, leukemia-associated viral proteins and vaccines
IL68749A (en) Modified antigens,their preparation and vaccines containing them
ZA851666B (en) Synthetic hepatitis b virus vaccine including both t cell and b cell determinants
PL268266A1 (en) The method of manufacture of proteins env virus aids
AU1365788A (en) Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
IL69776A0 (en) Aqueous microemulsions and their preparation
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
EP0283505A4 (en) VACCINE AND PRODUCTION METHOD.
AU1255383A (en) Foot and mouth disease viral antigenic peptides
IL67820A (en) Infectious bronchitis vaccines,their preparation and their use
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
DE3160264D1 (en) Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
GB2179449B (en) Improvements relating to viral isolates and their use
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
IE860983L (en) Antigens related to envelope glycoprotein of the virus of¹aids
IL83422A0 (en) Human b lymphotropic virus and method for the detection of antibodies thereto
GB8629472D0 (en) Rubella e1 glycoprotein antigens
GB8621578D0 (en) Hepatitis b viral antigens
GB8406901D0 (en) Virus vaccine
GR3003377T3 (en) Virus vaccine
GB8608991D0 (en) Virus vaccine